Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Raje

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
British Journal of Haematology|April 1, 1997
A comparison of vincristine and doxorubicin infusional chemotherapy with methylprednisolone (VAMP) with the addition of weekly cyclophosphamide (C-VAMP) as induction treatment followed by autografting in previously untreated myelomaN Raje, R Powles, S Kulkarni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2000
Ku86 variant expression and function in multiple myeloma cells is associated with increased sensitivity to DNA damageY T Tai, G Teoh, B Lin, et al.
British Journal of Haematology|August 8, 1998
A randomized trial of maintenance interferon following high-dose chemotherapy in multiple myeloma: long-term follow-up resultsD Cunningham, R Powles, J Malpas, et al.
Leukemia|November 29, 2016
Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myelomaK T Siu, J Ramachandran, A J Yee, et al.
Leukemia|July 4, 2008
Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myelomaI Breitkreutz, M S Raab, S Vallet, et al.
Leukemia|April 29, 2005
Antimyeloma activity of two novel N-substituted and tetraflourinated thalidomide analogsS Kumar, N Raje, T Hideshima, et al.
Blood|February 25, 1999
Detection of Kaposi's sarcoma herpesvirus DNA sequences in multiple myeloma bone marrow stromal cellsD Chauhan, A Bharti, N Raje, et al.
Leukemia|April 17, 2009
Ascorbic acid inhibits antitumor activity of bortezomib in vivoG Perrone, T Hideshima, H Ikeda, et al.
Bone Marrow Transplantation|November 1, 1996
Role of CD34+ cells in engraftment after high-dose melphalan in multiple myeloma patients given peripheral blood stem cell rescueB C Millar, J L Millar, J B Bell, et al.
Leukemia|March 16, 2011
A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast functionS Vallet, S Pozzi, K Patel, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
British Journal of Haematology|April 1, 1997
A comparison of vincristine and doxorubicin infusional chemotherapy with methylprednisolone (VAMP) with the addition of weekly cyclophosphamide (C-VAMP) as induction treatment followed by autografting in previously untreated myelomaN Raje, R Powles, S Kulkarni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2000
Ku86 variant expression and function in multiple myeloma cells is associated with increased sensitivity to DNA damageY T Tai, G Teoh, B Lin, et al.
British Journal of Haematology|August 8, 1998
A randomized trial of maintenance interferon following high-dose chemotherapy in multiple myeloma: long-term follow-up resultsD Cunningham, R Powles, J Malpas, et al.
Leukemia|November 29, 2016
Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myelomaK T Siu, J Ramachandran, A J Yee, et al.
Leukemia|July 4, 2008
Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myelomaI Breitkreutz, M S Raab, S Vallet, et al.
Leukemia|April 29, 2005
Antimyeloma activity of two novel N-substituted and tetraflourinated thalidomide analogsS Kumar, N Raje, T Hideshima, et al.
Blood|February 25, 1999
Detection of Kaposi's sarcoma herpesvirus DNA sequences in multiple myeloma bone marrow stromal cellsD Chauhan, A Bharti, N Raje, et al.
Leukemia|April 17, 2009
Ascorbic acid inhibits antitumor activity of bortezomib in vivoG Perrone, T Hideshima, H Ikeda, et al.
Bone Marrow Transplantation|November 1, 1996
Role of CD34+ cells in engraftment after high-dose melphalan in multiple myeloma patients given peripheral blood stem cell rescueB C Millar, J L Millar, J B Bell, et al.
Leukemia|March 16, 2011
A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast functionS Vallet, S Pozzi, K Patel, et al.
Pageof 6